Display options
Share it on

Infect Immun. 1970 Sep;2(3):309-15. doi: 10.1128/iai.2.3.309-315.1970.

Immunity in Experimental Salmonellosis I. Protection Induced by Rough Mutants of Salmonella typhimurium.

Infection and immunity

R Germanier

Affiliations

  1. Swiss Serum and Vaccine Institute, Berne, Switzerland.

PMID: 16557837 PMCID: PMC416007 DOI: 10.1128/iai.2.3.309-315.1970

Abstract

Different rough mutants of Salmonella typhimurium were tested to determine their virulence and immunizing capacity when used as live vaccines for mice. All uridine diphosphate-galactose-4-epimeraseless mutants tested were much more potent immunizing agents than any other mutants. This capacity was not correlated with virulence or complexity of cell wall polysaccharide. For good protection, persistence of the rough strains in vivo was essential, but the protection lasted longer than the period during which bacteria were demonstrable in the liver and spleen of the mice. The outstanding immunizing capacity of the "epimeraseless" mutants is not dependent on the persistence of viable bacteria in the mouse.

References

  1. Aust J Exp Biol Med Sci. 1968 Aug;46(4):447-63 - PubMed
  2. Keio J Med. 1965 Jun;14(2):45-61 - PubMed
  3. J Bacteriol. 1968 Jun;95(6):2014-21 - PubMed
  4. J Immunol. 1968 Feb;100(2):292-306 - PubMed
  5. Nature. 1968 Mar 9;217(5132):955-7 - PubMed
  6. Folia Microbiol (Praha). 1968;13(5):439-49 - PubMed
  7. Science. 1964 Aug 21;145(3634):783-9 - PubMed
  8. Nature. 1964 Mar 28;201:1301-2 - PubMed
  9. Bacteriol Rev. 1963 Dec;27:391-404 - PubMed
  10. Nature. 1962 Dec 15;196:1118-9 - PubMed
  11. Jpn J Exp Med. 1961 Jun;31:187-90 - PubMed
  12. J Bacteriol. 1961 Jun;81:863-8 - PubMed
  13. J Exp Med. 1966 Oct 1;124(4):585-600 - PubMed
  14. J Exp Med. 1966 Oct 1;124(4):573-83 - PubMed
  15. J Bacteriol. 1968 Feb;95(2):406-17 - PubMed

Publication Types